We are live on
!
Find out more
Asset Management One Portfolio holdings
AUM
$39B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.12%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.82%
5 Year Est. Return
+143.22%
10 Year Est. Return
+503.7%
AUM
$7.24B
AUM Growth
+$542M
(+8.1%)
Cap. Flow
+$601M
Cap. Flow
% of AUM
8.29%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
1,322
New
166
Increased
421
Reduced
404
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$23M |
| 2 |
Gilead Sciences
GILD
|
+$18.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$17.3M |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$16.3M |
| 5 |
Biogen
BIIB
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$20M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$13.1M |
| 3 |
RTN
Raytheon Company
RTN
|
+$10.6M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$10.5M |
| 5 |
Regency Centers
REG
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 30.07% |
| 2 | Healthcare | 13.94% |
| 3 | Technology | 8.1% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
76
DELISTED
PHARMACYCLICS INC
PCYC
| $20.4M | 0.28% |
169,109
+142,809
| +543% | +$16.3M |
|
77
SLB Ltd
SLB
$72.6B
| $19.8M | 0.27% |
192,592
-10,595
| -5% | -$1.16M |
|
78
Qualcomm
QCOM
$160B
| $19.6M | 0.27% |
262,061
+31,094
| +13% | +$2.38M |
|
79
Eli Lilly
LLY
$1.03T
| $19.5M | 0.27% |
298,862
+138,376
| +86% | +$8.76M |
|
80
Regeneron Pharmaceuticals
REGN
$77.4B
| $18.9M | 0.26% |
53,128
+41,710
| +365% | +$14M |
|
81
Northrop Grumman
NOC
$76B
| $18.9M | 0.26% |
143,437
-33,174
| -19% | -$4.19M |
|
82
Cisco
CSCO
$448B
| $18.8M | 0.26% |
747,213
-54,550
| -7% | -$1.37M |
|
83
Bausch Health
BHC
$2.25B
| $18.7M | 0.26% |
143,677
+123,477
| +611% | +$14.7M |
|
84
Tanger
SKT
$4.71B
| $18.7M | 0.26% |
566,736
-124,109
| -18% | -$4.29M |
|
85
Home Depot
HD
$332B
| $18.6M | 0.26% |
201,020
-10,449
| -5% | -$896K |
|
86
Tyson Foods
TSN
$21.4B
| $18.4M | 0.25% |
466,659
+8,757
| +2% | +$335K |
|
|
DRE
87
DELISTED
Duke Realty Corp.
DRE
| $18.2M | 0.25% |
1,046,551
-22,257
| -2% | -$402K |
|
88
Camden Property Trust
CPT
$11.2B
| $18.1M | 0.25% |
265,250
-12,866
| -5% | -$932K |
|
|
TCO
89
DELISTED
Taubman Centers Inc.
TCO
| $17.8M | 0.25% |
243,022
-9,622
| -4% | -$724K |
|
90
W.P. Carey
WPC
$16.9B
| $17.7M | 0.24% |
279,958
+90,869
| +48% | +$5.95M |
|
91
Southwest Airlines
LUV
$22.3B
| $17.4M | 0.24% |
516,117
-79,423
| -13% | -$2.43M |
|
|
BDN
92
Brandywine Realty Trust
BDN
$525M
| $17.3M | 0.24% |
1,211,688
+110,488
| +10% | +$1.71M |
|
93
EastGroup Properties
EGP
$11.3B
| $17.1M | 0.24% |
279,926
+15,730
| +6% | +$999K |
|
94
Teva Pharmaceuticals
TEVA
$41.2B
| $17M | 0.24% |
317,917
+239,857
| +307% | +$12.7M |
|
|
DFT
95
DELISTED
DuPont Fabros Technology Inc.
DFT
| $17M | 0.24% |
628,187
-10,897
| -2% | -$301K |
|
96
Extra Space Storage
EXR
$31.3B
| $17M | 0.23% |
328,278
-20,199
| -6% | -$1.07M |
|
|
HES
97
DELISTED
Hess
HES
| $16.8M | 0.23% |
177,291
+110,652
| +166% | +$10.9M |
|
|
MDVN
98
DELISTED
MEDIVATION, INC.
MDVN
| $16.8M | 0.23% |
334,722
+268,764
| +407% | +$11.4M |
|
99
Lockheed Martin
LMT
$132B
| $16.6M | 0.23% |
91,257
+10,975
| +14% | +$1.87M |
|
100
Highwoods Properties
HIW
$3.73B
| $16.5M | 0.23% |
421,953
+958
| +0.2% | +$40K |
|
Similar funds
Asset Management One's Q3 2014 Portfolio in Review
As of Q3 2014, Asset Management One held 1,322 positions worth $7.24B, up 8.1% from $6.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Asset Management One deployed $601M of net new capital in Q3 2014, opening 166 new positions and adding to 421 existing holdings. Its largest new stake was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
By sector, the portfolio is most concentrated in Real Estate at 30% of assets, down from 34% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was American Tower, an estimated $20M trimmed.
- Asset Management One's largest Q3 2014 buy was Ironwood Pharmaceuticals: 1,065,114 shares worth $11.9M.
- Asset Management One added most to AbbVie in Q3 2014, an estimated $23M increase.
- Asset Management One's biggest Q3 2014 reduction was American Tower, cutting an estimated $20M.
- Asset Management One fully exited Orbital ATK, Inc. in Q3 2014, selling an estimated $9.2M.
- Asset Management One's ten largest holdings make up 14% of its $7.24B portfolio in Q3 2014.
- Asset Management One opened 166 new positions and closed 77 in Q3 2014.
- Asset Management One's portfolio value rose 8.1% quarter-over-quarter to $7.24B.
Based on Asset Management One's 13F filing for Q3 2014, filed 5 Nov 2014.